Roivant Sciences Ltd (ROIV, Financial) is set to release its Q2 2025 earnings on Nov 12, 2024. The consensus estimate for Q2 2025 revenue is $49.22 million, and the earnings are expected to come in at -$0.26 per share. The full year 2025's revenue is expected to be $181.53 million and the earnings are expected to be -$0.73 per share. More detailed estimate data can be found on the Forecast page.
Roivant Sciences Ltd (ROIV, Financial) Estimates Trends
Over the past 90 days, revenue estimates for Roivant Sciences Ltd (ROIV) for the full year 2025 have increased from $152.81 million to $181.53 million. Conversely, the revenue estimates for 2026 have declined from $222.32 million to $206.51 million. Earnings estimates have also seen adjustments; for the full year 2025, estimates have risen from -$0.81 per share to -$0.73 per share. For 2026, the earnings estimates have improved from -$1.25 per share to -$1.20 per share.
Roivant Sciences Ltd (ROIV, Financial) Reported History
In the previous quarter of June 30, 2024, Roivant Sciences Ltd's (ROIV) actual revenue was $55.13 million, which beat analysts' revenue expectations of $31.50 million by 75.02%. Roivant Sciences Ltd's (ROIV) actual earnings were $0.12 per share, which beat analysts' earnings expectations of -$0.27 per share by 145.11%. After releasing the results, Roivant Sciences Ltd (ROIV) was up by 6.69% in one day.
Roivant Sciences Ltd (ROIV, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 8 analysts, the average target price for Roivant Sciences Ltd (ROIV) is $17.06 with a high estimate of $22 and a low estimate of $12.50. The average target implies an upside of 43.74% from the current price of $11.87.
Based on GuruFocus estimates, the estimated GF Value for Roivant Sciences Ltd (ROIV, Financial) in one year is $19.86, suggesting an upside of 67.31% from the current price of $11.87.
Based on the consensus recommendation from 11 brokerage firms, Roivant Sciences Ltd's (ROIV, Financial) average brokerage recommendation is currently 1.7, indicating an "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
